Literature DB >> 8318987

Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).

S Takeda1, S Ichii, Y Nakamura.   

Abstract

From 10 to 30% of lung carcinomas examined to date contain mutant K-ras genes. We report here that the mutant-allele-specific amplification (MASA) method may be useful for detection of the K-ras mutations in cells obtained from the sputum of patients with lung cancer. The PCR product from one of five patients revealed an alteration when mixed oligonucleotides representing variants of the second letter at codon 12 of this gene were used as 5' primers, and further experiments showed a mutation of GGT (Gly) to GAT (Asp) at codon 12. The MASA system could also be applied to an examination of metastatic lung carcinomas, particularly from adenocarcinomas in colon and pancreas in which frequent K-ras mutations are detected, and to mass-screening for colorectal tumors using DNA isolated from feces as template.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318987     DOI: 10.1002/humu.1380020209

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

Review 1.  Mucinous cystadenocarcinoma of the spleen presenting a point mutation of the Kirsten-ras oncogene at codon 12.

Authors:  M Hirota; N Hayashi; T Tomioka; S Murakami; H Ohshima; K Yamasaki; J Miyamoto; S Tamiya; M Ogawa
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

2.  Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers.

Authors:  Nobuyuki Hamajima; Toshiko Saito; Keitaro Matsuo; Kazuo Tajima
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

3.  Differences in carcinogenesis by the length of carcinogen exposure period in rat colon.

Authors:  T Endo; K Ookawa; M Tanaka; S Nakaji; S Tsuchida; K Sugawara
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  The tRNA-Tyr gene family of Saccharomyces cerevisiae: agents of phenotypic variation and position effects on mutation frequency.

Authors:  Sayoko Ito-Harashima; Phillip E Hartzog; Himanshu Sinha; John H McCusker
Journal:  Genetics       Date:  2002-08       Impact factor: 4.562

5.  Ampullary somatostatinoma in a patient with von Recklinghausen's disease.

Authors:  O Kainuma; Y Ito; T Taniguchi; T Shimizu; H Nakada; Y Date; T Hara
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

6.  Coexistence of choriocarcinoma and adenocarcinoma in the rectum: molecular aspects.

Authors:  M Tokisue; K Yasutake; M Oya; H Nishisaki; T Nakashima; H Hasegawa; Y Sakoda; T Kizaki; T Sashikata; R Morita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

7.  Development of a simple and sensitive technique for detection of point mutations in the K-ras oncogene.

Authors:  C Fernández-Vega; D C García-Olmo; M A Ballesteros; D García-Olmo
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

8.  Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay.

Authors:  Shoichi Matsukuma; Mitsuyo Yoshihara; Fumio Kasai; Akinori Kato; Akira Yoshida; Makoto Akaike; Osamu Kobayashi; Haruhiko Nakayama; Yuji Sakuma; Tsutomu Yoshida; Yoichi Kameda; Eiju Tsuchiya; Yohei Miyagi
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

9.  High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs.

Authors:  E Tsuchiya; R Furuta; N Wada; K Nakagawa; Y Ishikawa; B Kawabuchi; Y Nakamura; H Sugano
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.

Authors:  Ten-i Godai; Tetsuji Suda; Nobuhiro Sugano; Kazuhito Tsuchida; Manabu Shiozawa; Hironobu Sekiguchi; Akiko Sekiyama; Mitsuyo Yoshihara; Shoichi Matsukuma; Yuji Sakuma; Eiju Tsuchiya; Yoichi Kameda; Makoto Akaike; Yohei Miyagi
Journal:  BMC Cancer       Date:  2009-12-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.